Spontaneous subarachnoidal hemorrhage in patients with Covid-19: case report

Abstract

In this article, subarachnoidal hemorrhage developing in a case with Covid-19-related pneumonia was evaluated. In the presence of respiratory system infection signs such as cough and weakness in patient who present with sudden loss of consciousness, performing lung imaging as well as performing brain computerized tomography scan can allow the detection of an underlying Covid-19 infection.

Neurological Manifestations as the Predictors of Severity and Mortality in Hospitalized Individuals with COVID-19: A Multicenter Prospective Clinical Study

“…Each item can be scored from 0 to 4 and the total possible scores ranged from 0 to 42. Neurological impairments can be divided into four categories using NIHSS: a. mild (0-4), b. moderate (5)(6)(7)(8)(9)(10)(11)(12)(13)(14)(15), c. Moderate to severe (16)(17)(18)(19)(20), and d. severe . The intracerebral hemorrhage (ICH) score was also calculated in participants with ICH.…”

“…Myalgia, headaches, and loss of smell (anosmia) and taste (dysgeusia) sensations are common neurological ndings of the disease (7)(8)(9). Recent studies showed that SARS-CoV-2 could manifest as life-threatening neurological conditions including ischemic stroke, subarachnoid hemorrhage, status epilepticus, and acute demyelinating encephalomyelitis (10)(11)(12)(13). Neurological symptoms were also reported in epidemic outbreaks of other coronaviruses including SARS-CoV and the Middle East respiratory syndrome (MERS)-CoV (14,15).…”

Rehabilitation and COVID-19: the Cochrane Rehabilitation 2020 rapid living systematic review. Update as of August 31st, 2020

“…A detailed overview of the new evidence is provided in the supplementary Digital Material 1: Supplementary Table I (available on Cochrane Rehabilitation website: (https://tr.im/rr_dyn) 7 . Most studies (n=23) were conducted in Europe, 8 in Italy [8][9][10][11][12][13][14][15] , 4 in United Kingdom [16][17][18][19] , 3 in France [20][21][22] , 2 in Germany 23,24 , 2 in Switzerland 25,26 , 1 in Spain 27 , 1 in Portugal 28 , while 2 were performed as International European collaborations 29,30 ; Fifteen researches were performed in Asia (n=15), namely 3 in China [31][32][33] , 2 in Singapore 34,35 , 2 in Japan 36 , 2 in Turkey 37,38 , 2 in India 39,40 , 1 Iran 41 , 1 Kuwait 42 , 1 Pakistan 43 , 1 Taiwan 44 , whereas 11 in Americas , of whom 10 in United States of America (USA) [45][46][47][48][49][50][51][52][53][54] and 1 in Chile 55 . Two studies were carried out by Intercontin...…”

“…Due to the heterogeneity of published studies, a meta-analysis was not appropriate, so the results were qualitatively described. Based on the OCEBM 2011 Levels of Evidence table 58 the majority (76.5%) were level 4 (20 case report 8,16,18,19,21,23,[27][28][29][30]36,37,39,[42][43][44]47,49,51,53 , 10 case series 17,20,22,26,32,34,35,41,48,59 , and 9 historical cohort [9][10][11]13,15,24,[55][56][57] ), whereas the remainder 12 papers (23.5%) were of level 3 (6 cohort 12,25,33,40,46,50 and 6 cross sectional studies) 14,31,38,45,…”

“…According to the research question, the majority of studies (43.1%) investigated disease natural history/determining factors (1 cohort study 40 , 2 cross-sectional 52,54 , and 19 descriptive studies [8][9][10]19,20,27,29,30,32,[34][35][36]41,44,48,49,51,57,59 );14 descriptive papers reported epidemiological data on the clinical presentation of COVID-19 infection [16][17][18][21][22][23]26,28,37,39,42,43,47,53 , and 8 described disease prevalence (cohort study 46 , cross sectional 14,31,38,45 , historical cohort 15,24,56 ). Finally, 5 papers described data on health service organization (2 cohort studies 12,50 and 3 historical cohort COPYRIGHT© EDIZIONI MINERVA MEDICA studies 11, 13,…”